E10i-494
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
Lipid C12-A1 is an ionizable lipid. C12-A1-LPN is a potent and safe LNP platform to deliver Foxp3 mRNA to CD4+ T cells to engineer immunosuppressive FP3T cells. C12-A1 has a slightly lower average cell viability than C14-A1.
| CAS No. | Not available |
| Chemical Name | C12-A1 |
| Synonyms | C12A1 , C12 A1 |
| SMILES | C(CCCCCCCCCC)(O)CN(CCCCCN(CCN1CCN(CCCCCN(CC(CCCCCCCCCC)O)CC(CCCCCCCCCC)O)CC1)CC(CCCCCCCCCC)O)CC(CCCCCCCCCC)O |
| Formula | C76H157N5O5 |
| M.Wt | 1,220.22 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | mRNA Lipid Nanoparticles for Ex Vivo Engineering of Immunosuppressive T Cells for Autoimmunity Therapies Ajay S. Thatte, Alex G. Hamilton, Benjamin E. Nachod, Alvin J. Mukalel, Margaret M. Billingsley, Rohan Palanki, Kelsey L. Swingle, and Michael J. Mitchell*-Nano Letters-2023,Oct-30 |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 8.1952 mL | 1.6390 mL | 819.52 μL |
| 25 mg | 20.4881 mL | 4.0976 mL | 2.0488 mL |
| 50 mg | 40.9762 mL | 8.1952 mL | 4.0976 mL |
| 100 mg | 81.9524 mL | 16.3905 mL | 8.1952 mL |
| 250 mg | 204.8811 mL | 40.9762 mL | 20.4881 mL |
Contact our team with the catalog number and requested quantity.